Evidence map›Paper›PMID 29023555›Full record

Observational studyPloS one2017

Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.

Leticia Ferreyra-Reyes, Luis Pablo Cruz-Hervert, Stephanie B Troy, ChunHong Huang, Clea Sarnquist, Guadalupe Delgado-Sánchez, Sergio Canizales-Quintero, Marisa Holubar, Elizabeth Ferreira-Guerrero, Rogelio Montero-Campos and 4 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Leticia Ferreyra-ReyesInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Luis Pablo Cruz-HervertInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Stephanie B TroyEastern Virginia Medical School, Norfolk, Virginia, United States of America.
ChunHong HuangStanford University School of Medicine, Stanford, California, United States of America.
Clea SarnquistStanford University School of Medicine, Stanford, California, United States of America.
Guadalupe Delgado-SánchezInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Sergio Canizales-QuinteroInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Marisa HolubarStanford University School of Medicine, Stanford, California, United States of America.
Elizabeth Ferreira-GuerreroInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Rogelio Montero-CamposInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Mauricio Rodríguez-ÁlvarezFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Norma Mongua-RodriguezInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Yvonne MaldonadoStanford University School of Medicine, Stanford, California, United States of America.
Lourdes García-GarcíaInstituto Nacional de Salud Pública, Cuernavaca, Morelos, México.ORCID http://orcid.org/0000-0001-5262-1157
Instituto Nacional de Salud Pública · MXStanford University · USEastern Virginia Medical School · USUniversidad Nacional Autónoma de México · MX

Funding

Global Epidemiology of Infectious DiseasesT32AI052073 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud, Stephen Patrick Luby · 2003 to 2026
$4.2M
Oral Polio Vaccine Circulation in MexicoK23AI093678 · NIAID · EASTERN VIRGINIA MEDICAL SCHOOL · PI TROY, STEPHANIE B · 2011 to 2014
$507k
NIAID NIH HHS K23 AI093678NIAID NIH HHS T32 AI052073
6 · The paper itself

Abstract

backgroundMexico introduced inactivated polio vaccine (IPV) into its routine immunization (RI) schedule in 2007 but continued to give trivalent oral polio vaccine (tOPV) twice a year during national health weeks (NHW) through 2015.

objectivesTo evaluate individual variables associated with poliovirus (PV) shedding among children with IPV-induced immunity after vaccination with tOPV and their household contacts. MATERIALS AND

methodsWe recruited 72 children (both genders, ≤30 months, vaccinated with at least two doses of IPV) and 144 household contacts (both genders, 2 per household, children and adults) between 08/2010 and 09/2010 in Orizaba, Veracruz. Three NHW took place (one before and two after enrollment). We collected fecal samples monthly for 12 months, and tested 2500 samples for polioviruses types 1, 2 and 3 with three serotype-specific singleplex real-time RT-PCR (rRT-PCR) assays. In order to increase the specificity for OPV virus, all positive and 112 negative samples were also processed with a two-step, OPV serotype-specific multiplex rRT-PCR. ANALYSIS: We estimated adjusted hazard ratios (HR) and 95% CI using Cox proportional hazards regression for recurrent events models accounting for individual clustering to assess the association of individual variables with the shedding of any poliovirus for all participants and stratifying according to whether the participant had received tOPV in the month of sample collection.

results216 participants were included. Of the 2500 collected samples, using the singleplex rRT-PCR assay, PV was detected in 5.7% (n = 142); PV1 in 1.2% (n = 29), PV2 in 4.1% (n = 103), and PV3 in 1.9% (n = 48). Of the 256 samples processed by multiplex rRT-PCR, PV was detected in 106 (PV1 in 16.41% (n = 42), PV2 in 21.09% (n = 54), and PV3 in 23.05% (n = 59). Both using singleplex and multiplex assays, shedding of OPV among non-vaccinated children and subjects older than 5 years of age living in the same household was associated with shedding of PV2 by a household contact. All models were adjusted by sex, age, IPV vaccination and OPV shedding by the same individual during the previous month of sample collection.

conclusionOur results provide important evidence regarding the circulation of poliovirus in a mixed vaccination context (IPV+OPV) which mimics the "transitional phase" that occurs when countries use both vaccines simultaneously. Shedding of OPV2 by household contacts was most likely the source of infection of non-vaccinated children and subjects older than 5 years of age living in the same household.

Indexed as

Models, BiologicalPoliomyelitisPoliovirusVaccinationVirus SheddingAdolescentAdultChildChild, PreschoolFecesFemaleHumansMaleMexico

Identifiers

PMID29023555
PMCPMC5638237
OpenAlexW2760917107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.